Biblio

Export 206 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
J. - P. Coutu, Goldblatt, A., H Rosas, D., and Salat, D. H., “White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
R. L. Cowan, Beach, P. A., Atalla, S. W., Dietrich, M. S., Bruehl, S. P., Deng, J., Wang, J., Newhouse, P. A., Gore, J. C., and Monroe, T. B., “Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1633-1640, 2017.
S. Craft, Claxton, A., Baker, L. D., Hanson, A. J., Cholerton, B., Trittschuh, E. H., Dahl, D., Caulder, E., Neth, B., Montine, T. J., Jung, Y., Maldjian, J., Whitlow, C., and Friedman, S., “Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1325-1334, 2017.
K. M. Craven, Kochen, W. R., Hernandez, C. M., and Flinn, J. M., “Zinc Exacerbates Tau Pathology in a Tau Mouse Model.”, J Alzheimers Dis, vol. 64, no. 2, pp. 617-630, 2018.
A. Crestini, Santilli, F., Martellucci, S., Carbone, E., Sorice, M., Piscopo, P., and Mattei, V., “Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 503-518, 2022.
B. Cretin, Sellal, F., Philippi, N., Bousiges, O., Di Bitonto, L., Martin-Hunyadi, C., and Blanc, F., “Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?”, J Alzheimers Dis, vol. 52, no. 3, pp. 1125-33, 2016.
L. Crispoltoni, Stabile, A. Maria, Pistilli, A., Venturelli, M., Cerulli, G., Fonte, C., Smania, N., Schena, F., and Rende, M., “Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1005-1017, 2017.
S. M. Crivelli, Paulus, A., Markus, J., Bauwens, M., Berkes, D., De Vries, H. E., Mulder, M. T., Walter, J., Mottaghy, F. M., Losen, M., and Martinez-Martinez, P., “Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications.”, J Alzheimers Dis, vol. 60, no. 3, pp. 783-794, 2017.
P. S. Crooke, Tossberg, J. T., and Aune, T. M., “Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.”, J Alzheimers Dis, p. 13872877241313054, 2025.
A. J. Cross, George, J., Woodward, M. C., Ames, D., Brodaty, H., Wolfe, R., Connors, M. H., and Elliott, R. A., “Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.”, J Alzheimers Dis, vol. 60, no. 2, pp. 349-358, 2017.
E. Croteau, Castellano, C. - A., Richard, M. Anne, Fortier, M., Nugent, S., Lepage, M., Duchesne, S., Whittingstall, K., Turcotte, É. E., Bocti, C., Fülöp, T., and Cunnane, S. C., “Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 551-561, 2018.
M. L. Croze and Zimmer, L., “Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.”, J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
F. Crunfli, Mazucanti, C. Henrique, de Moraes, R. Carlos Mac, Costa, A. Pereira, Rodrigues, A. Cristina, Scavone, C., and Torrão, Ada Silva, “NO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin Resistance.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1427-1443, 2018.
Y. Rodríguez Cruz, Strehaiano, M., Obaya, T. Rodríguez, Rodríguez, J. César Gar, and Maurice, T., “An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 231-248, 2017.
Y. E. Cruz-Rivera, Perez-Morales, J., Santiago, Y. M., Gonzalez, V. M., Morales, L., Cabrera-Rios, M., and Isaza, C. E., “A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 193-205, 2018.
G. Cuberas-Borrós, Roca, I., Boada, M., Tárraga, L., Hernandez, I., Buendia, M., Rubio, L., Torres, G., Bittini, Á., Guzmán-de-Villoria, J. A., Pujadas, F., Torres, M., Núñez, L., Castell, J., and Páez, A., “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
D. Cuccaro, De Marco, E. Valeria, Cittadella, R., and Cavallaro, S., “Copy Number Variants in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 37-52, 2017.
I. Cuchillo-Ibañez, Balmaceda, V., Mata-Balaguer, T., Lopez-Font, I., and Sáez-Valero, J., “Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.”, J Alzheimers Dis, vol. 52, no. 2, pp. 403-16, 2016.
D. Cuervo-Zanatta, Garcia-Mena, J., and Perez-Cruz, C., “Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S195-S214, 2021.
C. Cui, Sekikawa, A., Kuller, L. H., Lopez, O. L., Newman, A. B., Kuipers, A. L., and Mackey, R. H., “Aortic Stiffness is Associated with Increased Risk of Incident Dementia in Older Adults.”, J Alzheimers Dis, vol. 66, no. 1, pp. 297-306, 2018.
J. Cummings, Ritter, A., and Zhong, K., “Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.”, J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
J. Cummings, Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Lebioda, K., Ginsberg, H. N., Winblad, B., Zetterberg, H., and Ray, K. K., “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
J. L. Cummings, Tong, G., and Ballard, C., “Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.”, J Alzheimers Dis, vol. 67, no. 3, pp. 779-794, 2019.
J. Cummings, Scheltens, P., McKeith, I., Blesa, R., Harrison, J. E., Bertolucci, P. H. F., Rockwood, K., Wilkinson, D., Wijker, W., Bennett, D. A., and Shah, R. C., “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
C. Cupidi, Frangipane, F., Gallo, M., Clodomiro, A., Colao, R., Bernardi, L., Anfossi, M., Conidi, M. Elena, Vasso, F., Curcio, S. Anna Maria, Mirabelli, M., Smirne, N., Torchia, G., Muraca, M. Gabriella, Puccio, G., Di Lorenzo, R., Zampieri, S., Romanello, M., Dardis, A., Maletta, R. Giovanni, and Bruni, A. Cecilia, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.

Pages